𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Maternal serum marker levels in two pregnancies affected with Smith-Lemli-Opitz syndrome

✍ Scribed by Jacob A. Canick; Dianne N. Abuelo; Linda A. Bradley; G. S. Tint


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
43 KB
Volume
17
Category
Article
ISSN
0197-3851

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Prenatal diagnosis of Smith–Lemli–Opitz
✍ D. P. Bick,; D. McCorkle; W. S. Stanley; H. J. Stern; P. Staszak; G. D. Berkovit 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 1 views

A cytogenetically normal male fetus was subsequently found to have female external genitalia, a cardiac malformation and mid-trimester intra-uterine growth retardation by ultrasound examination. The maternal serum oestriol level was low. The combination of low oestriol and sonographic findings sugge

Hypothalamic-pituitary-gonadal function
✍ Pankau, Rainer ;Partsch, Carl-Joachim ;Funda, Johannes ;Sippell, Wolfgang Günthe 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

## Abstract We report on the hypothalamic‐pituitary‐gonadal function in 2 male infants with the Smith‐Lemli‐Opitz (SLO or RSH) syndrome. Both infants had abnormal external genitalia. Basal and LHRH stimulated plasma gonadotropins were normal for age (1 month). Plasma testosterone, androstenedione,

Maternal serum activin A and follistatin
✍ H. S. Cuckle; I. Sehmi; R. Jones; L. W. Evans 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

Inhibin A is now an established second-trimester maternal serum marker of Down syndrome. Since activin A has a common -subunit to inhibin A we evaluated this substance and its binding protein, follistatin, as potential markers. We studied 30 affected and 199 unaffected pregnancies at 13-16 weeks' ge

Dehydrosteroid measurements in maternal
✍ Cedric H.L. Shackleton; Josep Marcos; Glenn E. Palomaki; Wendy Y. Craig; Richard 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Abstract In a large multi‐center trial involving prenatal screening for Smith–Lemli–Opitz syndrome (SLOS), we evaluated maternal urine and serum steroid analysis as a non‐invasive diagnostic alternative to amniotic fluid sterol analysis. Candidate steroid ratios included: 7‐dehydropregnanetriol/